Trazodone for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Trazodone is a prescription serotonin antagonist and reuptake inhibitor (SARI). In horses, your vet may use it extra-label to reduce anxiety, improve tolerance of confinement, and make some handling situations safer. It is not FDA-approved specifically for horses, so dosing and monitoring need to be individualized.

In published equine studies, trazodone was absorbed fairly quickly after oral dosing, with peak blood levels often reached within about 10 to 45 minutes after a single dose. Its effects can include calming, mild sedation, and reduced movement, which is why it is sometimes considered for horses on stall rest or for short-term behavior support.

This medication is not the same as injectable standing sedation used for procedures. Oral trazodone may take the edge off for some horses, but response is variable. Some horses become calmer, while others may still be reactive or may become too sedated or unsteady.

Because horses are large, doses can require many tablets or a compounded formulation. Your vet may also consider the horse's temperament, cardiac history, bleeding risk, breeding status, and whether the horse is competing, since trazodone is a prohibited substance in many performance settings.

In equine practice, trazodone is most often used to help horses that are anxious during stall confinement. That can matter after injury or surgery, when a horse needs to stay quieter to protect healing tissues. Research in healthy horses found that oral trazodone reduced step counts and produced measurable sedation, especially at higher doses.

Your vet may also use trazodone as part of a plan for handling stress, such as difficult bandage changes, recheck visits, or short-term transport anxiety. It is usually one piece of a broader strategy that may also include environmental changes, careful scheduling, behavior modification, and sometimes other medications.

Trazodone is not a pain medication, and it does not replace proper treatment for the underlying problem. If a horse is restless because of pain, colic, neurologic disease, or respiratory distress, calming the horse without addressing the cause can be risky.

For performance horses, another practical issue is competition compliance. Trazodone has been identified as a prohibited substance in racing and other regulated settings, so pet parents should tell your vet if the horse may be shown, raced, or tested.

There is no one-size-fits-all equine trazodone dose. Published studies have evaluated oral doses around 2.5 to 10 mg/kg, with common clinical discussion centered around roughly 4 to 7.5 mg/kg by mouth, and some research using 7 mg/kg every 12 hours as a clinically relevant repeated-dose regimen. In one pharmacokinetic study, horses given 7.5 or 10 mg/kg showed sedation and ataxia, with more oversedation seen at 10 mg/kg.

A later repeated-dose study found that 7.5 mg/kg every 12 hours reduced ambulation in stalled horses and produced sedation lasting up to about 8 hours after dosing in healthy adults. Another 2024 study showed quantifiable sedation at 3 mg/kg and 6 mg/kg, although trazodone did not reduce the amount of xylazine needed to reach a target sedation endpoint.

In real-world use, your vet may start at the lower end and adjust based on the horse's size, age, medical history, and how much calming is needed. Because response can vary, your vet may recommend a test dose on a quiet day before a stressful event. Never increase the dose on your own, and do not ride or trailer a horse unless your vet says it is safe after dosing.

Trazodone is usually given orally as tablets or a compounded preparation. Since a 500 kg horse may need a large total milligram dose, administration logistics matter. Your vet may give instructions about timing with feed, how to split doses, and what signs mean the next dose should be delayed or the medication stopped.

The most common side effects reported in horses are sedation and ataxia, meaning the horse may look sleepy, less responsive, or unsteady. In studies, these effects could begin within 20 to 30 minutes of dosing. Mild calming may be the goal, but too much sedation can increase the risk of stumbling, falling, or unsafe behavior.

Higher doses have been associated with more concerning reactions, including oversedation, muscle fasciculations, sweating, transient tachycardia or arrhythmias, soft manure, and colic signs. In one repeated-dose study, one horse developed a prolonged episode of sinus tachycardia with sweating and flight behavior after a 7.5 mg/kg dose, though it resolved without intervention.

There is also emerging concern about platelet function and bleeding risk. Cornell researchers describe trazodone as widely used in horses and are actively studying whether clinically relevant dosing may reduce platelet function, even if routine blood counts stay normal. That does not mean every horse will have a bleeding problem, but it is an important discussion before surgery or in horses with known clotting concerns.

Call your vet promptly if your horse seems very weak, severely uncoordinated, unusually agitated, has a fast or irregular heartbeat, sweats heavily, stops eating, develops diarrhea, or shows colic signs. See your vet immediately if the horse collapses, cannot stay standing, has trouble breathing, or appears neurologic.

Trazodone can interact with other medications that affect the brain, heart rhythm, blood pressure, or serotonin signaling. In horses, this matters most when it is combined with other sedatives or calming drugs, because the horse may become more sedated or more ataxic than expected.

Your vet will want to know about any recent or planned use of alpha-2 sedatives such as xylazine, detomidine, or romifidine; phenothiazines such as acepromazine; opioids such as butorphanol; and other behavior medications. Even if a combination is sometimes used intentionally, it should be planned and monitored rather than improvised.

Because trazodone may affect serotonin pathways, caution is also reasonable with other serotonergic drugs. In addition, if platelet effects are confirmed clinically, combining trazodone with drugs that may influence bleeding or perioperative risk could become more important in surgical patients.

Always give your vet a full medication and supplement list, including compounded products, calming pastes, and show-day supplements. Do not combine trazodone with another sedative because a previous dose "didn't work" unless your vet specifically instructs you to do that.